|
Volumn 9, Issue 5, 2001, Pages 331-337
|
Brazil fights for affordable drugs against HIV/AIDS
[No Author Info available]
|
Author keywords
Acquired immune deficiency syndrome; Brazil; Drug industry; Health economics; World Trade Organization
|
Indexed keywords
ANTIRETROVIRUS AGENT;
EFAVIRENZ;
NELFINAVIR;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
BRAZIL;
DRUG APPROVAL;
DRUG COST;
DRUG INDUSTRY;
GOVERNMENT;
HEALTH CARE ACCESS;
HEALTH CARE AVAILABILITY;
HEALTH CARE DISTRIBUTION;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH PROGRAM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
INFECTION PREVENTION;
LAW;
PATENT;
PHARMACEUTICAL CARE;
PUBLIC HEALTH SERVICE;
UNITED NATIONS;
WORLD HEALTH ORGANIZATION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
BRAZIL;
COMMERCE;
DRUG INDUSTRY;
HIV INFECTIONS;
HUMANS;
PATENTS;
UNITED STATES;
WORLD HEALTH ORGANIZATION;
|
EID: 0034944451
PISSN: 10204989
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|